Abstract
Synaptotagmin (syt) I, an integral membrane protein localized to secretory vesicles, is a putative Ca2+ sensor for exocytosis. Its N terminus spans the membrane once, and its cytoplasmic domain contains two conserved C2 domains, designated C2A and C2B. The isolated C2A domain penetrates membranes in response to Ca2+; isolated C2B does not. Here, we have addressed the function of each C2 domain, but in the context of the intact cytoplasmic domain (C2A-C2B), by using fluorescent reporters placed in the Ca2+-binding loops of either C2A or C2B. Surprisingly, these reporters revealed that, analogous to C2A, a Ca2+-binding loop in C2B directly penetrates into lipid bilayers. Penetration of each C2 domain was very rapid (kon ≈1010 M−1⋅s−1) and resulted in high affinity C2A-C2B–liposome complexes (Kd ≈13–14 nM). C2B-bilayer penetration strictly depended on the presence, but not the membrane binding activity, of an adjacent C2A domain, severing C2A from C2B after protein synthesis abolished the ability of C2B to dip into bilayers in response to Ca2+. The activation of C2B by C2A was also displayed by the C2 domains of syt III but not the C2 domains of syt IV. A number of proteins contain more than one C2 domain; the findings reported here suggest these domains may harbor cryptic activities that are not detected when they are studied in isolation.
Keywords: exocytosis‖liposome‖fluorescence‖cooperativity‖fusion
Communication between neurons is mediated by the Ca2+-triggered release of neurotransmitters from docked synaptic vesicles (1). The Ca2+-binding synaptic vesicle protein, synaptotagmin (syt) I, has been proposed to function as a Ca2+ sensor that triggers release (2–4). Syt I spans the vesicle membrane once and possesses a large cytoplasmic domain largely composed of two C2 domains (5), each of which function as Ca2+-sensing modules (6–8). To understand the molecular mechanism by which syt may regulate exocytosis, the immediate consequences of Ca2+ binding have been studied. The best characterized Ca2+-triggered effector interaction is between the C2A domain and membranes. In the presence of Ca2+, two Ca2+-binding loops of C2A directly penetrate into lipid bilayers (9–11). This interaction potentially drives lipid rearrangements that underlie fusion (2, 10) as supported by a genetic study (4).
Despite its homology to C2A (≈40%), the isolated C2B domain of syt fails to penetrate membranes in response to Ca2+ (12, 13). This was somewhat surprising because the function of C2 domains, in a number of enzymes, is to mediate Ca2+-triggered translocation to membranes where they can interact with substrate (reviewed in ref. 14). In a recent study, we observed that in the context of the intact cytoplasmic domain of syt (designated C2A-C2B), mutations that abolish Ca2+-triggered C2A–membrane interactions did not abolish the ability of the cytoplasmic domain to bind liposomes in response to Ca2+ (13). These data suggested that C2B rescues activity in the mutant C2A domain or that C2A activates a cryptic membrane penetration activity within C2B.
Here, we have used site-directed fluorescent probes to distinguish between these two models. Interestingly, these data demonstrate that C2A activates a cryptic membrane penetration activity in an adjacent C2B domain. These findings establish a form of cooperativity between tandem C2 domains that was not anticipated from studies of isolated C2 domains, resulting in a model for syt–membrane interactions.
Materials and Methods
Recombinant Proteins.
cDNA encoding rat syt I (G374) (8, 15), III (16), and IV (17) were kindly provided by G. Schiavo (Imperial Cancer Research Fund), S. Seino (Chiba University, Chiba, Japan), and H. Herschman (University of California, Los Angeles), respectively. The cytoplasmic (designated C2A-C2B, residues 96–421), C2A (residues 96–265), and C2B (residues 248–421) domains of syt I (G374 version) were expressed in Escherichia coli as glutathione S-transferase fusion proteins and purified by using glutathione-Sepharose beads (Amersham Pharmacia) as described (18, 19). Point mutations and chimeras were prepared by using the overlapping primer method as described (7).
In C2A-C2B, Cys-277 was replaced with Ala, then a single Cys was placed in loop 3 of the C2A domain (F234C; indicated as C2A*-C2B) or in an analogous position in the C2B domain (I367C; indicated as C2A-C2B*). In C2AM*-C2B and C2AM-C2B*, the subscript M corresponds to D230,232N substitutions that disrupt the Ca2+ and lipid binding activity of C2A (22). cDNA encoding these constructs were subcloned into pGEX-2T (Amersham Pharmacia) using BamHI and EcoRI sites.
In his6-C2A-TC-C2B*, TC indicates a thrombin cleavage site (LVPRGS) that was inserted into the linker domain between C2A and C2B (after residue 268). This construct was His-6 tagged at its N terminus by subcloning into the pTrcHis A vector (Invitrogen) by using EcoRI and XhoI. The protein was purified on Ni-NTA-agarose (Qiagen, Chatsworth, CA) as described (19).
All chimeras were expressed as glutathione S-transferase fusion proteins using pGEX vectors; their compositions were as follows: C2AM III-C2B I, residues 290–421 of III (with two Ca2+ ligand mutations, D385,387N) and residues 264–421 of I (20); C2AM I-C2B III, residues 96–272 (containing two Ca2+ ligand mutations, D230,232N) of I and residues 430–569 of III; C2A IV-C2B, residues 152–278 of IV and 264–421 of I; and C2AM I-C2B IV, residues 96–272 of I (containing two mutations at the Ca2+ binding sites, D230,232N) and residues 288–425 of IV.
Labeling of the Single Cys Mutants of C2A-C2B by 5-[[2-[(Iodoacetyl)amino]ethyl]amino]naphthalene-1-sulfonic Acid (IAEDANS).
Cys residues were labeled by incubation of proteins with a 10-fold molar excess of 1,5-IAEDANS (Molecular Probes) at 25°C for 1 h in Hepes buffer (50 mM Hepes-NaOH, pH 7.4/0.1 M NaCl). Free fluorophore was removed using Sephadex G-25 desalting columns (Amersham Pharmacia), and residual probe was removed by dialysis. The AEDANS concentration was determined using an extinction coefficient of 6.0 × 103 M−1⋅cm−1 at 337 nm (23). The protein concentration was determined by Coomassie blue staining of proteins separated by SDS/PAGE using BSA as a standard. Labeling ratios were 0.85–0.95 mole label/mole of protein.
Liposomes.
Brain-derived phosphatidylserine (PS), phosphatidylcholine (PC), 1-palmitoyl-2-stearoyl (5-doxyl)-sn-glycero-3-phosphocholine (5-doxyl-PC), 1-palmitoyl-2-stearoyl (7-doxyl)-sn-glycero-3-phosphocholine (7-doxyl-PC), and 1-palmitoyl-2-stearoyl (12-doxyl)-sn-glycero-3-phosphocholine (12-doxyl-PC) were obtained from Avanti Polar Lipids. For fluorescence studies, large (≈100 nm) unilamellar liposomes were prepared as described by Davis et al. (10).
L-3-phosphatidyl[N-methyl-3H]choline-1,2-dipalmitoyl ([3H]PC) was purchased from Amersham Pharmacia, and 3H-labeled liposome-binding assays were carried out as described by Davis et al. (10). Error bars represent the standard deviations from triplicate determinations.
Fluorescence Measurements.
Steady-state fluorescence measurements were made at 24°C using a PTI (South Brunswick, NJ) QM-1 fluorometer and felix software. Labeled protein (0.5 μM) was mixed with liposomes (11 nM liposomes = 1 mM lipid) in a cuvette using a castle-style stir bar. AEDANS was excited at 336 nm, and emission spectra were collected from 420 to 600 nm (2-nm slits). Emission spectra were corrected for blank, dilution, and instrument response. The depth of the fluorophore penetration into bilayers was calculated according to the parallax analysis described by Bai et al. (11). The distance from the bilayer center to the shallow quencher (5-doxyl-PC) was taken as 5.85 Å (24). [Ca2+]free was determined as described in Davis et al. (10). For stopped-flow rapid mixing experiments, AEDANS-labeled proteins were excited at 336 nm, and emitted light was collected by using a 470-nm cutoff filter. These experiments and calculations were carried out as described in ref. 10.
Results
A lone Trp residue, placed at the distal tip of Ca2+-binding loop 3 of C2A, shows membrane penetration of the loop as an increase in intensity and a blue shift in the emission spectrum (9–11). To explore the possibility that C2B, in the context of C2A-C2B, also penetrates into membranes, we placed a fluorescent reporter at the analogous position in its Ca2+-binding loop 3 (position Ile-367 as determined using the crystal structures of syt I and III as templates) (20, 21). Because C2A-C2B contains a number of Trp residues that are critical for its function (data not shown), we substituted Ile-367 with a cysteine (Cys) residue and labeled it with an AEDANS. As a positive control, the equivalent position in C2A (Phe-234 in loop 3) was also changed to a Cys and labeled with AEDANS (Fig. 1A).
Consistent with previous studies using Trp probes, the label on the C2A domain (designated C2A*-C2B) exhibited a Ca2+-triggered increase in the fluorescence intensity and blue shift in its emission spectrum when mixed with liposomes containing acidic phospholipids (25% PS/75% PC unless otherwise indicated). These changes depended on addition of both liposomes and Ca2+ (Fig. 1B Left) (9–11) and result from the Ca2+-driven penetration of the Ca2+-bound loop, harboring the fluorescent label, into the hydrophobic phase of the lipid bilayer (refs. 9 and 11; also described in detail below). Membrane penetration requires the presence of acidic phospholipids (25% PS); the fluorescent reporters did not penetrate liposomes composed of only PC (refs. 6, 7, and 11 and data not shown). This is likely because of the need for acidic phospholipid head groups to complete the Ca2+ coordination sites; anionic lipids probably interact with basic residues in the Ca2+-binding loops (9, 21, 25, 26).
We then used this approach to address the possibility that C2B might also penetrate bilayers. As shown in Fig. 1B (Right), the fluorescence of an AEDANS label on Ca2+-binding loop 3 of C2B (designated C2A-C2B*) exhibited strikingly similar fluorescence changes upon addition of Ca2+ and liposomes; i.e., an increase in fluorescence intensity and a blue shift in the emission spectra [in the absence of liposomes, Ca2+ causes a slight (<1%) decrease in fluorescence]. These data support a model in which C2A activates a cryptic membrane penetration activity within C2B.
We next determined whether the interactions of C2A*-C2B and C2A-C2B* with membranes are rapid enough to couple Ca2+ influx to fusion using a stopped-flow rapid mixing approach. Rapid mixing of liposomes with C2A*-C2B or C2A-C2B* in EGTA resulted in an unchanging baseline fluorescence signal (Fig. 1C). Rapid mixing of liposomes with C2A*-C2B or C2A-C2B* in Ca2+ resulted in a rapid and marked increase in the fluorescence signal (Fig. 1C). These increases were well fitted with single exponential functions to determine the observed rate, kobs. We then measured kobs as a function of the [liposome]; these data are plotted in Fig. 1D; the Y-intercept yields koff and the slope yields kon. These values were 146.6 ± 6.9 s−1/1.06 ± 0.09 × 1010 M−1⋅s−1 for C2A*-C2B and 134.6 ± 9.3 s−1/1.07 ± 0.12 × 1010 M−1⋅s−1 for C2A-C2B*. If C2A and C2B function as independent domains, these studies indicate that they exhibit similar affinities for membranes; the calculated dissociation constants from these kinetics data are 13–14 nM for each of the reporter constructs. As we reported for the isolated C2A domain, the on-rates for C2A*-C2B or C2A-C2B* membrane interactions approach the collisional limit and more than satisfy the kinetic constraints of exocytosis (27, 28).
The optical reporters were also used to measure steady-state Ca2+ dependencies for the penetration of C2A and C2B into membranes, again in the context of C2A-C2B. When a reporter in C2A is monitored, the [Ca2+]1/2 for binding was 69 ± 1.4 μM (Hill coefficient = 2.3; Fig. 1E). Similar results were obtained when the reporter in C2B was monitored ([Ca2+]1/2 = 53 ± 1.3 μM; Hill coefficient = 3.2; Fig. 1E). These values are in the range of the Ca2+ requirements for secretion measured in different cell types (from ≈10 to 200 μM Ca2+; refs. 28–30).
To confirm that the increase in fluorescence of C2A-C2B* results from penetration of the reporter into bilayers, we carried out quenching experiments using the membrane-embedded fluorescence quencher, doxyl-PC. Doxyl groups are efficient quenchers of AEDANS fluorescence, but because the quencher is located on the acyl chain of the lipid (Fig. 2B Right), quenching can occur only if the fluorophore penetrates into the bilayer. As shown in Fig. 2A, the reporters in C2A*-C2B and C2A-C2B* were efficiently quenched. The degree of quenching by labels at the 5, 7, and 12 positions of the acyl chain indicated that the reporters penetrated ≈1/6th into the hydrophobic core of the bilayer. These results are shown schematically in Fig. 2B, where both C2A and C2B simultaneously penetrate into the hydrophobic core of lipid bilayers, “pinning” the protein to the bilayer surface.
To rule out the possibility that the lipid binding activity of C2A “drags” C2B into membranes, we generated a construct harboring mutations that abolish C2A–membrane interactions (C2AM-C2B). We then placed fluorophores in loop 3 of either C2 domain (designated C2A*M-C2B and C2AM-C2B*). The mutations in C2A strongly inhibited the increase in fluorescence of the C2A probe that results from insertion into bilayers (Fig. 3A Upper), excluding the model in which C2B “repairs” mutations within C2A. In contrast, these mutations had only slight effects on the increase in fluorescence of the fluorescent reporter in C2B (Fig. 3A Middle and Lower). To confirm that mutations in C2A affect the penetration of C2A, but have little effect on the penetration of C2B, we used membrane-embedded quenchers as described above. The relative degree of quenching of reporters placed in the C2A domain was diminished by Ca2+-ligand mutations in C2A (Fig. 3B Upper). In contrast, the Ca2+ ligand mutations in C2A had little effect on the strong quenching of the fluorophore on C2B (Fig. 3B Middle and Lower). These experiments clearly demonstrate that the ability of C2B to penetrate lipid bilayers is not by means of a passive process in which C2A “drags” C2B. Rather, when C2A is adjacent to C2B, a cryptic lipid penetration activity within C2B is activated. It is interesting that this activation occurs even by using a C2A domain, which itself is not active (discussed further below).
In light of these findings, we sought to better understand the mechanism by which C2A “activates” a cryptic Ca2+-triggered lipid penetration activity within C2B. When isolated C2B is expressed and purified, it fails to penetrate lipid bilayers in the AEDANS fluorescence assay (Fig. 4A). We considered two possibilities for this lack of activity: that C2A is needed for correct folding of an active C2B domain or that C2A interacts with C2B to activate it after the protein is synthesized. We addressed the question by engineering a thrombin cleavage site between C2A and C2B (Fig. 4B; designated C2A-TC-C2B). We expressed and purified a His-6-tagged version of C2A-TC-C2B and showed that the C2B domain can penetrate into lipid bilayers using an AEDANS reporter placed in loop 3 (Fig. 4C Top). We then cleaved C2B from C2A by using thrombin. Because this reaction was highly inefficient (≈3% of the protein was cleaved), we assayed whether the conditions used to carry out cleavage affected the ability of C2A-TC-C2B* to penetrate membranes and found that this activity was not diminished (Fig. 4C Middle). We purified cleaved C2B from the fusion protein and assayed its ability to interact with membranes. Analogous to C2B purified as an isolated domain (Fig. 4A); C2B* liberated from C2A also failed to penetrate membranes (Fig. 4C Bottom). These data indicate that the role of C2A is not to direct folding of C2B, but rather that C2A interacts with C2B by means of a novel mechanism that activates cryptic Ca2+-triggered membrane penetration properties within C2B, potentially by means of physical contact between the adjacent C2 domains. A recent fluorescence resonance energy transfer study indicates that C2A and C2B can come into closer proximity, albeit at millimolar divalent metal concentrations (31).
Syt IV does not bind liposomes in response to Ca2+ (32). This isoform harbors a naturally occurring serine at position 244, which corresponds to a glutamate residue at position 230 in the C2A domain of syt I. In syt I, this glutamate is a critical Ca2+ ligand; neutralization by replacement with a serine abolishes Ca2+-triggered lipid binding activity of the isolated C2A (22). “Reversal” of this mutation in the C2A domain of syt IV, by means of an S244D substitution, results in robust Ca2+-triggered lipid binding activity (33). However, all of the conserved Ca2+ ligands are present in the C2B domain of syt IV. Thus, it is surprising that the C2A domain of syt IV does not activate its C2B domain (Fig. 5). These data indicate that either C2A of IV lacks the “activation” activity for C2B or C2B from IV lacks the ability to be activated by C2A. We addressed this issue by generating chimeras between syts I and IV; as controls, syt I/III chimeras were analyzed in parallel. We first observed that the C2A domain of syt IV failed to activate the lipid binding activity of the C2B domain of syt I. In contrast, the C2AM domain of syt III (D385,387N) was able to activate C2B from isoform I. We next observed that the D230,232N mutant form of the C2A domain of syt I (C2AMI), which can activate the C2B domain of syts I and III, fails to activate the C2B domain of syt IV. These data indicate that syt IV harbors more than one loss of function; the C2A domain not only fails to penetrate membranes, it also fails to activate the C2B domain of the protein. Furthermore, the C2B of syt IV lacks the ability to be activated by a C2A domain capable of activating other C2B domains. According to these experiments, syt IV harbors additional differences in both C2 domains that disrupt its ability to interact with membranes, consistent with its putative role as an inhibitory syt (34, 35).
Discussion
C2 domains are widespread conserved motifs; to date, 123 human genes encoding proteins that contain C2 domains have been identified (36). These domains are ≈140 residues in length and fold into compact eight-stranded β-sandwiches with flexible loops that protrude from one end (14, 21). In many, but not all, cases, these loops (1 and 3) mediate the binding of divalent metals, which often seems to regulate the binding of the C2 domain to other molecules including lipids and proteins (reviewed in ref. 14). In some proteins, the function of C2 domains seems to be straightforward. For example, Ca2+ triggers the translocation of C2 domain harboring phospholipases to membranes where their catalytic domains can efficiently turn-over substrate. In other cases, e.g., SYT, potential functions for C2 domains are less clear. syt was the first membrane protein identified that harbored C2 domains. Biochemical studies demonstrated that the C2A domain of syt I is an autonomously folding Ca2+ and lipid-binding module (6, 7). In the Ca2+-bound state, the Ca2+-binding loops of C2A rapidly penetrate into lipid bilayers at Ca2+ concentrations that trigger exocytosis (9–11). Positively charged amino acids within the loops interact with acidic phospholipid head groups. Neutralization of one of the positively charged residues in Ca2+-binding loop 3 has been reported to increase the Ca2+ requirements for lipid binding and to reduce evoked secretion at hippocampal synapses (4). Together, these data are consistent with a model in which Ca2+-triggered syt–membrane interactions serve as a coupling step in exocytosis. The isolated C2B domain of syt I also “senses” Ca2+ (8), but in contrast to C2A, Ca2+ does not drive the penetration of isolated C2B into membranes (12, 13).
More recently, it was discovered that the initial syt clone harbored a mutation that disrupts activities within the C2B domain (8), prompting a reevaluation of the role of C2A and C2B in mediating Ca2+-triggered interactions with membranes. New data demonstrated that mutations that abolished the Ca2+-triggered lipid binding activity of C2A did not abolish the overall Ca2+-triggered lipid binding activity of C2A-C2B; yet, isolated C2B fails to efficiently bind liposomes in response to Ca2+ (13). Here, we report that C2B penetrates into membranes in response to Ca2+, but only when tethered to an adjacent C2A domain. Interestingly, the penetration of C2B does not depend on the lipid-binding activity of C2A. However, severing C2A from C2B, after protein synthesis, disrupted the ability of the Ca2+-binding loop of C2B to insert into membranes. These data demonstrate that C2A does not activate C2B by directing folding during protein synthesis. This finding is not surprising because isolated C2B still senses Ca2+ and does not seem to be misfolded (8). Thus, C2A actively influences the properties of C2B.
This is a striking example of the evolution of multidomain proteins in which activities/properties arise or are lost by means of the use of domain repeats. It is possible that the C2B domain of syt I lost autonomous activity during evolution, giving rise to this form of cooperativity. This cooperativity may underlie the regulation of both C2 domains by molecules that interact with either C2A or C2B. For Ca2+-triggered lipid-binding activity, this is true of syts I and III (13) but not syt IV. We found that the C2 domains of syt IV exhibit a number of differences in comparison to syt I: not only is its C2A domain incapable of binding lipids in response to Ca2+, it is incapable of activating the lipid-binding activity within the C2B domain of syt I. Furthermore, the C2B domain of syt IV cannot be activated by the C2A domain of syt I (Fig. 5). These properties of syt IV are consistent with a proposed role as a seizure-induced (17) inhibitory isoform of the protein (34, 35).
A model for the structure of the syt–membrane complex is shown in Fig. 2B. In the absence of Ca2+, syt forms a weak precomplex with membranes (data not shown). In this view, Ca2+ influx would drive penetration of C2A and C2B into the vesicle or plasma membrane (11) with very rapid kinetics (Fig. 1C). If Ca2+-triggered syt–membrane interactions are crucial for exocytosis, neutralization of Ca2+ ligands within C2A may result in a mild phenotype because the mutant protein would retain the ability to penetrate bilayers in response to Ca2+. Penetration into the plasma membrane could help pull the bilayers together to facilitate soluble N-ethylmaleimide-sensitive fusion protein attachment receptor catalyzed fusion. For example, in at least some fusion events, a dimple in the plasma membrane forms as the target membrane is pulled toward the vesicle membrane (reviewed in ref. 37).
Acknowledgments
We thank X. Xia, E. Mussak, M. Jackson, C. Earles, A. Bhalla, and H. J. Kim for their help. This study was supported by National Institutes of Health Grant NIGMS GM 56827, American Heart Association Grant 9750326N, and a grant from the Milwaukee Foundation. E.R.C. is a Pew Scholar in the Biomedical Sciences. J.B. is supported by an American Health Association Predoctoral Fellowship.
Abbreviations
- syt
synaptotagmin
- PS
phosphatidylserine
- PC
phosphatidylcholine
- IAEDANS
5-[[2-[(iodoacetyl)amino]ethyl]amino]naphthalene-1-sulfonic acid
Footnotes
This paper was submitted directly (Track II) to the PNAS office.
References
- 1.Augustine G J. Curr Opin Neurobiol. 2001;11:320–326. doi: 10.1016/s0959-4388(00)00214-2. [DOI] [PubMed] [Google Scholar]
- 2.Brose N, Petrenko A G, Südhof T C, Jahn R. Science. 1992;256:1021–1025. doi: 10.1126/science.1589771. [DOI] [PubMed] [Google Scholar]
- 3.Littleton J T, Bai J, Vyas B, Desai R, Baltus A E, Garment M B, Carlson S D, Ganetzky B, Chapman E R. J Neurosci. 2001;21:1421–1433. doi: 10.1523/JNEUROSCI.21-05-01421.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fernandez-Chacon R, Konigstorfer A, Gerber S H, Garcia J, Matos M F, Stevens C F, Brose N, Rizo J, Rosenmund C, Südhof T C. Nature (London) 2001;410:41–49. doi: 10.1038/35065004. [DOI] [PubMed] [Google Scholar]
- 5.Perin M S, Fried V A, Mignery G A, Jahn R, Südhof T C. Nature (London) 1990;345:260–263. doi: 10.1038/345260a0. [DOI] [PubMed] [Google Scholar]
- 6.Davletov B, Südhof T. J Biol Chem. 1993;268:26386–26390. [PubMed] [Google Scholar]
- 7.Chapman E R, Jahn R. J Biol Chem. 1994;269:5735–5741. [PubMed] [Google Scholar]
- 8.Desai R, Vyas B, Earles C, Littleton J T, Kowalchyck J, Martin T F J, Chapman E R. J Cell Biol. 2000;150:1125–1135. doi: 10.1083/jcb.150.5.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chapman E R, Davis A F. J Biol Chem. 1998;273:13995–14001. doi: 10.1074/jbc.273.22.13995. [DOI] [PubMed] [Google Scholar]
- 10.Davis A F, Bai J, Fasshauer D, Wolowick M J, Lewis J L, Chapman E R. Neuron. 1999;24:363–376. doi: 10.1016/s0896-6273(00)80850-8. [DOI] [PubMed] [Google Scholar]
- 11.Bai J, Earles C, Lewis J, Chapman E R. J Biol Chem. 2000;275:25427–25435. doi: 10.1074/jbc.M906729199. [DOI] [PubMed] [Google Scholar]
- 12.Schiavo G, Gu Q M, Prestwich G D, Söllner T H, Rothman J E. Proc Natl Acad Sci USA. 1996;93:13327–13332. doi: 10.1073/pnas.93.23.13327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Earles C A, Bai J, Wang P, Chapman E R. J Cell Biol. 2001;154:1117–1123. doi: 10.1083/jcb.200105020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nalefski E A, Falke J J. Protein Sci. 1996;5:2375–2390. doi: 10.1002/pro.5560051201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Osborne S L, Herreros J, Bastiaens P I H, Schiavo G. J Biol Chem. 1999;274:59–66. doi: 10.1074/jbc.274.1.59. [DOI] [PubMed] [Google Scholar]
- 16.Mizuta M N, Inagaki N, Nemoto Y, Matsukura S, Takahashi M, Seino S. J Biol Chem. 1994;269:11675–11678. [PubMed] [Google Scholar]
- 17.Vician L, Lim I K, Ferguson G, Tocco G, Baudry M, Herschman H R. Proc Natl Acad Sci USA. 1995;92:2164–2168. doi: 10.1073/pnas.92.6.2164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chapman E R, Hanson P I, An S, Jahn R. J Biol Chem. 1995;270:23667–23671. doi: 10.1074/jbc.270.40.23667. [DOI] [PubMed] [Google Scholar]
- 19.Chapman E R, An S, Edwardson J M, Jahn R. J Biol Chem. 1996;271:5844–5849. doi: 10.1074/jbc.271.10.5844. [DOI] [PubMed] [Google Scholar]
- 20.Sutton R B, Ernst J A, Brunger A T. J Cell Biol. 1999;147:589–598. doi: 10.1083/jcb.147.3.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sutton R B, Davletov B A, Berghuis A M, Südhof T C, Sprang S R. Cell. 1995;80:929–938. doi: 10.1016/0092-8674(95)90296-1. [DOI] [PubMed] [Google Scholar]
- 22.Zhang X, Rizo J, Südhof T C. Biochemistry. 1998;37:12395–12403. doi: 10.1021/bi9807512. [DOI] [PubMed] [Google Scholar]
- 23.Hudson E N, Weber G. Biochemistry. 1973;12:4154–4161. doi: 10.1021/bi00745a019. [DOI] [PubMed] [Google Scholar]
- 24.Chung L A, Lear J D, DeGrado W F. Biochemistry. 1992;31:6608–6616. doi: 10.1021/bi00143a035. [DOI] [PubMed] [Google Scholar]
- 25.Grobler J A, Essen L O, Williams R L, Hurley J H. Nat Struct Biol. 1996;3:788–795. doi: 10.1038/nsb0996-788. [DOI] [PubMed] [Google Scholar]
- 26.Chae Y K, Abildgaard F, Chapman E R, Markley J L. J Biol Chem. 1998;273:25659–25663. doi: 10.1074/jbc.273.40.25659. [DOI] [PubMed] [Google Scholar]
- 27.Llinas R, Steinberg I Z, Walton K. Biophys J. 1981;33:323–352. doi: 10.1016/S0006-3495(81)84899-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Heidelberger R, Heinemann C, Matthews G. Nature (London) 1994;371:513–515. doi: 10.1038/371513a0. [DOI] [PubMed] [Google Scholar]
- 29.Bollman J H, Sakmann B, Borst J G G. Science. 2000;289:953–957. doi: 10.1126/science.289.5481.953. [DOI] [PubMed] [Google Scholar]
- 30.Schneggenburger R, Neher E. Nature (London) 2000;406:889–893. doi: 10.1038/35022702. [DOI] [PubMed] [Google Scholar]
- 31.Garcia R A, Forde C, Godwin H A. Proc Natl Acad Sci USA. 2000;97:5883–5888. doi: 10.1073/pnas.100127197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chapman E R, Desai R, Davis A F, Tornhel C. J Biol Chem. 1998;273:32966–32972. doi: 10.1074/jbc.273.49.32966. [DOI] [PubMed] [Google Scholar]
- 33.VonPoser C, Ichtchenko K, Shao X, Rizo J, Südhof T C. J Biol Chem. 1997;272:14314–14319. doi: 10.1074/jbc.272.22.14314. [DOI] [PubMed] [Google Scholar]
- 34.Littleton J T, Sereno T L, Rubin G M, Ganetzky B, Chapman E R. Nature (London) 1999;400:757–760. doi: 10.1038/23462. [DOI] [PubMed] [Google Scholar]
- 35.Wang C-T, Grishanin R, Earles C A, Chang P Y, Martin T F J, Chapman E R, Jackson M B. Science. 2001;294:1111–1115. doi: 10.1126/science.1064002. [DOI] [PubMed] [Google Scholar]
- 36.International Human Genome Sequencing Consortium. Nature (London) 2001;409:860–921. [Google Scholar]
- 37.Monck J R, Fernandez J M. Neuron. 1994;12:707–716. doi: 10.1016/0896-6273(94)90325-5. [DOI] [PubMed] [Google Scholar]